RNF170 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.618200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.682200E-01
Normal-vs-Stage2
9.552800E-01
Normal-vs-Stage3
9.395600E-02
Normal-vs-Stage4
9.662800E-01
Stage1-vs-Stage2
3.802400E-01
Stage1-vs-Stage3
2.091800E-02
Stage1-vs-Stage4
5.759000E-01
Stage2-vs-Stage3
1.584170E-01
Stage2-vs-Stage4
9.040200E-01
Stage3-vs-Stage4
2.108000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.441600E-01
Normal-vs-AfricanAmerican
7.733800E-01
Normal-vs-Asian
9.356200E-01
Caucasian-vs-AfricanAmerican
8.591800E-01
Caucasian-vs-Asian
9.990600E-01
AfricanAmerican-vs-Asian
8.477400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.907200E-01
Normal-vs-Female
8.834800E-01
Male-vs-Female
6.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.965800E-01
Normal-vs-Age(41-60Yrs)
7.646000E-01
Normal-vs-Age(61-80Yrs)
7.959400E-01
Normal-vs-Age(81-100Yrs)
6.563000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.374800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.812800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.104600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.171600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.113570E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.089000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.374600E-01
Normal-vs-Daily Drinker
9.859000E-01
Normal-vs-Weekly Drinker
6.669400E-01
Normal-vs-Occasional Drinker
6.857200E-01
Normal-vs-Social Drinker
9.896800E-01
Non Drinker-vs-Daily Drinker
5.218800E-01
Non Drinker-vs-Weekly Drinker
9.548200E-01
Non Drinker-vs-Occasional Drinker
4.527700E-02
Non Drinker-vs-Social Drinker
2.332000E-01
Daily Drinker-vs-Weekly Drinker
5.980600E-01
Daily Drinker-vs-Occasional Drinker
5.663000E-01
Daily Drinker-vs-Social Drinker
9.739800E-01
Weekly Drinker-vs-Occasional Drinker
1.592390E-01
Weekly Drinker-vs-Social Drinker
4.061000E-01
Occasional Drinker-vs-Social Drinker
4.097200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.006100E-02
Normal-vs-Grade 2
2.880300E-02
Normal-vs-Grade 3
5.277500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.348800E-01
Grade 1-vs-Grade 3
1.974630E-01
Grade 1-vs-Grade 4
6.006100E-02
Grade 2-vs-Grade 3
2.912800E-01
Grade 2-vs-Grade 4
2.880300E-02
Grade 3-vs-Grade 4
5.277500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.343000E-01
Normal-vs-NonDiabetic
9.102800E-01
Diabetic-vs-NonDiabetic
6.228800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.998600E-01
Normal-vs-NoPancreatitis
8.176200E-01
Pancreatitis-vs-NoPancreatitis
4.942600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.575800E-01
Normal-vs-N1
9.499600E-01
N0-vs-N1
9.667600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.087400E-01
Normal-vs-TP53-NonMutant
8.637600E-01
TP53-Mutant-vs-TP53-NonMutant
1.863820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
